Differential effects of T-cell inhibitors and antimetabolites on graft survival in high-risk penetrating keratoplasty: A tertiary center experience

Key Points

• To compare the effects of T-cell inhibitors and antimetabolites on graft survival in patients undergoing high-risk penetrating keratoplasty.
• Comparison of T-cell inhibitors and antimetabolites in high-risk penetrating keratoplasty cases
• Focus on cases involving repeat grafts
• Evaluation of graft survival rates over time
• T-cell inhibitors demonstrate improved graft survival compared to antimetabolites
• Repeat grafting shows varied success rates based on treatment type
• Findings suggest that medication choice influences outcomes in high-risk patients